logo
  Join        Login             Stock Quote

Angiodynamics (ANGO) Posts Better Than Expected Q2; Cuts 2013 Revenue Forecast

 January 03, 2013 04:27 PM
 


(By Balaseshan) AngioDynamics Inc. (NASDAQ: ANGO) reported better-than-expected quarterly earnings on double-digit growth from its international, VenaCure EVLT and Oncology/Surgery divisions. The maker of diagnostic devices, however, lowered its 2013 revenue forecast.

On a non-GAAP basis, earnings per share (EPS) for the second quarter declined to 10 cents from 11 cents, while topping market expectations by a penny.

On a GAAP basis, earnings declined to $2 million or $0.06 per share from $2.3 million or $0.09 per share. The latest quarter results include costs related to the Navilyst Medical acquisition, the subsequent restructuring of the company and the Quality Call to Action Program.

[Related -Stock Market Opening Report - October 12, 2012]

Sales jumped 50 percent to $87.01 million, while Wall Street analysts' projected $87.39 million for the second quarter.

Pro forma net sales increased 3%. U.S. net sales decreased 1%, while International sales climbed 21% (22% on a constant currency basis). Vascular net sales rose 1%, while Oncology/Surgery sales increased 12%.

Looking ahead for fiscal 2013 ending May, the company still expects non-GAAP EPS in the range of $0.40 to $0.42. ANGO cut its sales outlook to range of $355 million to $360 million from previous forecast of $361 million to $364 million. Analysts expect EPS of $0.40 on sales of $359.75 million.

ANGO closed Thursday's regular session down 2.10% at $11.18. The stock has been trading between $10 and $15.02 for the past 52 weeks.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageInitial Jobless Claims Rose Unexpectedly

Claims unexpectedly rose in the latest report through last weekend to breach 300,000 for the first time read on...

article imageAll Quiet on the Record High Front

What can we glean from the media’s lack of attention to the market’s recent record read on...

article imageThe Chip Maker Short Sellers Should Be Watching

Investing in semiconductor stocks is always tricky. Industry cycles can lead to bumps in the road for the read on...

article imageChicago Fed: US Economic Growth Slowed In October

The pace of US growth slowed more than expected in October, according to this morning’s update of the read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.